Intertwined growth charts forming a healthy baby

Growth Chart Face-Off: Decoding Your Baby's Development

"Are CDC and WHO growth charts telling you different stories? Unraveling the complexities of infant growth assessment."


Monitoring a child's growth is a cornerstone of pediatric care, acting as an early warning system for potential health and nutritional issues. Two prominent sets of guidelines, those from the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), are frequently used to evaluate a child's development. However, these guidelines can sometimes provide conflicting information, leaving parents and caregivers puzzled.

This article delves into a study that examines the agreement between the CDC and WHO growth references when assessing the growth of infants. The research, conducted in São Paulo and Ribeirão Preto, Brazil, analyzed data from 254 children aged 3 to 11 months to determine how consistently the two sets of guidelines classified their growth patterns.

Understanding the nuances of these growth charts is crucial for ensuring that children receive appropriate care and interventions when needed. We'll break down the study's findings, highlighting key differences between the CDC and WHO guidelines and offering insights to help you navigate your child's growth journey.

AI Search Multiple angles on this topic

Growth Charts and Milestone Checklists

U.S. pediatric growth charts use percentile curves to show the distribution of selected body measurements in children. Pediatricians, nurses, and parents have used them to track growth since 1977; the original charts were developed by the National Center for Health Statistics (NCHS). The CDC says its free developmental milestone checklists can assist with early identification, while noting that further research is needed on best practices for surveillance, screening, and referral.

CDC vs. WHO: Unpacking the Differences in Growth Assessment

Intertwined growth charts forming a healthy baby

The study meticulously compared growth assessments based on both the CDC and WHO guidelines, focusing on key anthropometric indicators such as weight-for-height and height-for-age. These indicators help healthcare providers determine if a child is growing at a healthy rate and identify potential issues like underweight or stunted growth.

Researchers used Kappa and weighted Kappa tests to measure the agreement between the two sets of guidelines. The Kappa test assesses the level of agreement between two methods, with values ranging from 0 to 1 (higher values indicating stronger agreement).

  • Weight-for-height: Compares a child's weight to their height, helping to identify underweight or overweight conditions.
  • Height-for-age: Reflects a child's height relative to their age, indicating long-term growth and potential stunting.
AI Search Multiple angles on this topic

New Directions in Growth Charts

The WHO Multicentre Growth Reference Study says its new growth curves are expected to offer a single international standard describing physiological growth from birth to age five, with the breastfed infant as the normative model. In a study published August 18, 2025, researchers sought to create growth charts that gradually transition between WHO and CDC charts. They also sought to evaluate the impact of those charts on young children’s growth assessments using real-world data.

Limits of Growth Charts

The CDC says there is little research on what BMI calculated from length means in infancy or what its consequences may be. It also cautions that growth charts are not intended to be used as a sole diagnostic instrument. These limitations mean the charts should not be treated as a standalone diagnosis or as definitive evidence about the meaning of infant BMI calculated from length.

Population Differences in Growth

In the WHO Multicentre Growth Reference Study, differences in length ranged from -0.33 to +0.49 standard deviation units (SDs), and differences in height ranged from -0.41 to +0.46 SDs; most values were below 0.2 SDs. A systematic review describes exceptions, including a study in which children in Iceland averaged about two-thirds of an SD longer than the MGRS charts at birth and 12 months. The review also reports that male and female infants in Denmark were outliers up to age 1, noting that the Icelandic study was small while the Danish study was a large national survey.

The study revealed notable differences in how the CDC and WHO guidelines classified infant growth. While there was moderate to high agreement for some indicators, discrepancies emerged, particularly in the height-for-age assessment for younger infants (3-6 months). This suggests that the two guidelines may lead to different conclusions about whether a child's growth is on track.

Interpreting Growth Charts: What Parents Need to Know

The findings underscore the importance of understanding that growth charts are tools, not definitive diagnoses. A single data point should never be the sole basis for concern or intervention. Instead, growth charts should be used in conjunction with a holistic assessment of the child's overall health, development, and nutritional intake.

If you notice discrepancies between CDC and WHO growth charts for your child, don't panic. Discuss your concerns with your pediatrician or a registered dietitian. They can provide personalized guidance based on your child's specific circumstances and medical history.

Ultimately, the goal is to ensure that children receive the support they need to reach their full developmental potential. By understanding the strengths and limitations of different growth assessment tools, parents and healthcare providers can work together to promote healthy growth and well-being.

What the chart comparisons represent

The WHO standard describes growth under optimal environmental and health conditions, while the CDC reference describes growth among children in the United States. Those are different comparison frames, not interchangeable claims about what caused a child’s measurements.[1]

A percentile or Z-score locates a measurement relative to peers of the same age and sex. It indicates comparative growth status, not by itself why a child is that size.[2]

How population comparisons complicate the picture

The review describes contrasting feeding-group comparisons in Japan: breastfed children were below the MGRS mean, while formula-fed children were closer to it or not as low. Greek breastfed infants, by contrast, showed no consistent pattern against national standards and MGRS data.[3]

The review also reports outlying populations in Iceland and Denmark; it notes that the Icelandic sample was small, whereas the Danish evidence came from a large national survey. This difference in study scale matters when weighing how broadly each comparison may apply.[3]

In the German comparison, researchers judged differences from the MGRS curves sufficient to favor national growth curves. That judgment illustrates that an international reference may not fit every population equally well.[3]

Known population differences mean an international standard could classify children from smaller-bodied populations as having poor growth, potentially prompting unnecessary testing and parental distress.[2]

What further comparisons could clarify

  • How much do the length-to-stature measurement change and its associated difference affect classifications around the chart transition?[4]
  • How consistently would an international standard classify growth across populations with different body-size patterns, and when might those classifications lead to unnecessary follow-up?[2]

About this Article -

Written with AI assistance from published research, and reviewed by the Mystum team. See our About page for more information.

Everything You Need To Know

1

Why is monitoring a child's growth so important?

Monitoring a child's growth is crucial for pediatric care, serving as an early warning system for potential health and nutritional issues. The two primary sets of guidelines used for assessment are the CDC and WHO growth charts. Understanding how these tools work and any differences is key to appropriate care.

2

What are the main differences between the CDC and WHO growth charts?

The CDC and WHO guidelines can sometimes provide conflicting information when assessing infant growth. Discrepancies may arise, particularly in height-for-age assessments, which can lead to different conclusions about a child's growth trajectory. This highlights the importance of considering both sets of guidelines and a broader assessment of the child.

3

Where was the study about the CDC and WHO growth charts conducted and what methods were used?

The study analyzed data from 254 children, aged 3 to 11 months, in São Paulo and Ribeirão Preto, Brazil. The research employed Kappa and weighted Kappa tests to measure the agreement between CDC and WHO guidelines. The Kappa test assesses the agreement between the CDC and WHO methods, with higher values indicating stronger agreement.

4

What are weight-for-height and height-for-age, and why are they important?

Weight-for-height compares a child's weight to their height, while height-for-age reflects a child's height relative to their age. These anthropometric indicators help healthcare providers assess growth and identify potential problems like underweight, overweight, or stunted growth. The CDC and WHO guidelines use these indicators to evaluate whether a child is growing at a healthy rate.

5

How should parents interpret the information provided by the CDC and WHO growth charts?

Growth charts, such as those from the CDC and WHO, are tools, not definitive diagnoses. It's essential to consider a child's overall health, development, and nutritional intake in conjunction with growth chart data. The healthcare providers must consider multiple data points and conduct a holistic assessment to determine the need for any interventions. A single data point alone should not trigger concern or action.

Newsletter Subscribe

Subscribe to get the latest articles and insights directly in your inbox.